| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 07/29/2026 | ±4.8% | -2.0% | over-priced |
| 04/29/2026 | ±3.3% | +0.1% | over-priced |
| 10/22/2025 | ±2.8% | +4.1% | under-priced |
| 07/24/2025 | ±3.3% | +0.3% | over-priced |
| 04/25/2025 | ±3.7% | -1.2% | over-priced |
| 10/23/2024 | ±2.7% | +0.5% | over-priced |
| 07/24/2024 | ±2.7% | -2.1% | over-priced |
| 04/24/2024 | ±2.6% | -0.9% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $0.52 | $9.0B | $815M |
| Q1 FY2026 | $0.50 | $8.7B | $761M |
| Q4 FY2025 | $0.55 | $9.7B | $800M |
| Q3 FY2025 | $0.50 | $8.9B | $774M |
SLB Limited (SLB) reports in 72 days, with the next report estimated for 11/23/2026. Across the last 8 reports, options priced an average ±3.2% earnings move while the stock actually moved 1.4% on average — the market has systematically over-priced SLB's earnings risk. Fundamentals into the print: EPS down 29.7% year-over-year, revenue up 5.0%. QuantLogix's live 5-factor engine currently reads SLB as a buy at 66/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →